Genetic Diagnostics Technologies Corp.
TSX VENTURE : GDD

Genetic Diagnostics Technologies Corp.

August 25, 2006 08:02 ET

Genetic Diagnostics Technologies Corp. Announces Appointment of Jim Beatty to the Board of Directors

TORONTO, ONTARIO--(CCNMatthews - Aug. 25, 2006) -

(Not for dissemination in the United States of America)

Genetic Diagnostics Technologies Corp. (the "Company") (TSX VENTURE:GDD) announces that Gerald Hatch resigned from the board of directors of the Company (the "Board"), effective as of June 6, 2006. By unanimous resolution of the Board as then constituted, effective as of June 8, 2006, James D. ("Jim") Beatty was appointed to fill the vacancy on the Board created by Mr. Hatch's resignation, until the next following annual meeting of the Company. Mr. Hatch has agreed to continue serving the Company in an advisory capacity, and has been appointed by the Board as a special (non-voting) advisor and consultant to the Board, effective as of June 8, 2006.

Jim Beatty is the President of Trinity Capital Corporation, which he founded in 1982; and of Trinity Capital Securities Limited, which he founded in 1988. With over 30 years' experience in the investment industry, Jim has, for the past 15 years, focused on the financing and development of small and medium-sized enterprises. He has sat on 30 public company boards in both Canada and the United States, and presently sits on four public company boards. Mr. Beatty is past President of the Association for Corporate Growth, and is a frequent guest lecturer at York University and the University of Toronto. He earned his M.B.A. and another graduate degree from the University of Toronto.

About the Company

Based in Toronto, the Company is a development-stage DNA diagnostics company that has licensed and continues to further develop a revolutionary diagnostic platform that it intends to commercialize in Canada and the United Sates.

The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Genetic Diagnostics Technologies Corp.
    Stephen C. Johnston
    President and Chief Executive Officer
    (416) 360-3469
    Website: www.dna3.com